Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- befree-2016 importedOn "2016-02-19" NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_assertion wasGeneratedBy ECO_0000203 NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_assertion wasDerivedFrom befree-2016 NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_assertion SIO_000772 21140256 NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_assertion evidence source_evidence_literature NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.
- NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_assertion description "[Males (age 18) with ADRA2A CG genotype, when compared to other participants, tended to have higher drug use especially when they had s/s genotype of 5-HTTLPR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857569.RA2DCBnWa4eQ5eXn_XEL9Gr6kYxPWcvFZQPVSFwD4EaUY130_provenance.